- Boosts reach of CSAM Prosang blood management solution to service all 5
national regions across Denmark                      

Oslo, Norway, July 28th, 2021: CSAM Health Group AS ("CSAM"), the leading
provider of niche eHealth solutions in the Nordics, today announced it has
signed a contract with the five regions within the Danish health authority for
CSAM's Prosang blood, cell, and tissue management system for blood banks. In an
agreement between CSAM and all five health regions, the new contract will
translate to approximately NOK 75-100 million NOK over at the next six years and
will be implemented in all blood banks in the country.

Until today, the CSAM Prosang solution was rolled out in four of five Danish
regions: Mid Jylland, North Jylland, South Denmark and Sjælland. The new
nation-wide contract, including the country's fifth region, Region Hovedstaden
(Capital Region), secures CSAM's position as niche provider of blood bank
management services for national health providers across the country. 

- "We are pleased to enter this new agreement with CSAM Health Group, that
essentially enables the Danish health regions to provide a nationwide,
consolidated solution for blood bank management services," says Kim Brixen,
Chairman of the Steering Group.

- "All current CSAM Prosang installations in Denmark, in addition to the new
installation in the Copenhagen region will be migrated into a national service
supporting data quality, security, information sharing, workflow support and
integrations."

The new e-health solutions agreement reconfirms CSAM's sustainability, adding
another national market win and further enhancing its strong Nordic leadership
within niche e-health solutions.

- "In December 2019, CSAM reached 100% market share in Sweden within the blood
bank management segment when we signed an agreement with Region Skåne," says
Daniel Wiman, Product Manager at CSAM.

- "Four of the five Danish regions have been using the CSAM ProSang solution for
several years in separate installations throughout the country. Thus, we are
very excited that now all health regions have selected ProSang as their common
platform and preferred national blood bank management program for blood, cells,
and tissues," continues," continues Wiman.  

According to CSAM, the complete Danish national installation will service
thousands of regular users, manage over 300.000 blood donations, several hundred
transplants, and approximately 700.000 examinations every year.

About CSAM Prosang
CSAM ProSang, Scandinavia's leading blood, cell, and tissue management system,
is an advanced Laboratory Information Management System (LIMS) that simplifies
the entire management of blood, cells and tissues - from donation to transfusion
or transplantation. Today, Prosang is employed in five countries and operational
at over 180 blood centres in 27 healthcare regions.

CSAM's benchmark bouquet of benchmark eHealth solutions 
CSAM's strategy is to gather the best e-health software services solutions on
the market into one unique family to provide a complete portfolio of benchmark.
CSAM is harnessing best-of-breed technology and solutions to empower its
customers to do what they do best. 
Contacts:

Media contact CSAM
Leslie Johnsen
Interim Communications Director
+47 41 45 80 43
Leslie.johnsen@csamhealth.com

Investor relations CSAM
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com 

About CSAM
CSAM has established itself as a leading Nordic niche player in the specialised
eHealth market with a unique blend of best-in-class innovative technology, and
outstanding human skills. The company's diverse portfolio of software solutions
enables healthcare providers to access relevant clinical information at the
point of care. CSAM's commercial headquarters are located in Oslo, Norway. In
addition, CSAM has 17 local offices in 10 countries in Europe, Asia and North
America.

For more information, visit www.csamhealth.com. 

Follow us on LinkedIn and Twitter.

Subscribe to our newsletter: http://eepurl.com/dsoOJH

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange